Patent · US Active

Quantitative antibody test

US11686730B2 · kind B2 · utility

0Cited by
31References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 28, 2021
Grant dateJun 27, 2023
Priority date
Expiry dateApr 28, 2041

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2469/20
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present disclosure relates to methods and compositions, e.g., kits, for quantitatively detecting an antibody of a subject to an infectious organism. In some embodiments, the present disclosure provides for methods and compositions, e.g., kits, for quantitatively detecting a human antibody to SARS-CoV-2 polypeptide or S (spike) polypeptide. Certain applications and uses of the present methods and compositions, e.g., kits, are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.